Search
for
Sort by
Research 241–270 of 1000+
- Matriptase: Potent Proteolysis on the Cell Surface
- Chemoprevention – History and general principles
- Hedgehog Pathway Inhibitors against Tumor Microenvironment
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Recent Developments in Luteolin-Loaded Nanoformulations for Enhanced Anti-Carcinogenic Activities: Insights from In Vitro and In Vivo Studies
- Acquired hypertrichosis lanuginosa: Case report and review of the literature
- Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies
- Biological Function of Long Non-coding RNA (LncRNA) Xist
- Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
- Prevention of Alopecia in Medical and Interventional Chemotherapy Patients
- Extraskeletal actions of vitamin D
- Melatonin Receptors and Their Role in Human Diseases
- Androgen receptors and their biology
- Roles of tumor suppressors in regulating tumor-associated inflammation
- The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites
- Reporting on Adverse Clinical Events
- Sex hormones and related compounds, including hormonal contraceptives
- Cutaneous Drug Reaction Case Reports
- Australasian Society for Dermatology Research Meeting, May 2006
- Adipocyte-Derived Stem and Regenerative Cells in Facial Rejuvenation
- Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
- Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect
- Full‐body skin examination in screening for cutaneous malignancy: A focus on concealed sites and the practices of international dermatologists
- Treatment of Chemotherapy Induced Alopecia
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Whole brain radiotherapy with partial hair-sparing technique-a feasibility study
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023